MDT
美敦力 Medtronic plc
+0.17 (+0.18%)92.77USD1.9M成交股數119B市值22.9本益比(近四季)3.2股價營收比+13.7%營收年增(近四季)2026-11-17下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 1 · 258K · 1 |
| 其中 10b5-1 計畫賣出 | 1 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 595K |
| 近 180 天 淨額 | −595K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | 09-17 | Blomquist Denise L. | Chief Accounting Officer | G 贈與 | 600 | – | – | 16.4K | SEC |
| 2026-08-20 | 08-24 | Marinaro Michael | EVP, Pres MedSurg and Americas | F 繳稅扣股 | 1.1K | 92.30 | 100K | 116K | SEC |
| 2026-08-03 | 08-04 | KIIL HARRY SKIP | EVP & President Cardiovascular | A 獲配股票 | 9.2K | – | – | 43.7K | SEC |
| 2026-08-03 | 08-04 | Marinaro Michael | EVP, Pres MedSurg and Americas | A 獲配股票 | 11.0K | – | – | 71.3K | SEC |
| 2026-08-03 | 08-04 | Quinn Michelle | EVP, GC and Secretary | A 獲配股票 | 6.3K | – | – | 26.7K | SEC |
| 2026-08-03 | 08-04 | Blomquist Denise L. | Chief Accounting Officer | A 獲配股票 | 2.3K | – | – | 17.0K | SEC |
| 2026-08-03 | 08-04 | Walter Matthew R. | SVP, Chief HR Officer | A 獲配股票 | 5.8K | – | – | 39.9K | SEC |
| 2026-08-03 | 08-04 | Martha Geoffrey | Chairman and CEO | A 獲配股票 | 41.5K | – | – | 328K | SEC |
| 2026-08-03 | 08-04 | Marinaro Michael | EVP, Pres MedSurg and Americas | A 獲配股票 | 46.1K | – | – | 117K | SEC |
| 2026-08-03 | 08-04 | Pieton Thierry | EVP & Chief Financial Officer | A 獲配股票 | 11.5K | – | – | 49.6K | SEC |
| 2026-08-03 | 08-04 | Thompson Kweli | EVP & President, Neuroscience | A 獲配股票 | 6.9K | – | – | 35.4K | SEC |
| 2026-07-31 | 08-04 | KIIL HARRY SKIP | EVP & President Cardiovascular | F 繳稅扣股 | 3.1K | 85.39 | 262K | 34.4K | SEC |
| 2026-07-31 | 08-04 | Thompson Kweli | EVP & President, Neuroscience | F 繳稅扣股 | 1.7K | 85.39 | 148K | 28.5K | SEC |
| 2026-07-31 | 08-04 | Blomquist Denise L. | Chief Accounting Officer | F 繳稅扣股 | 212 | 85.39 | 18K | 14.7K | SEC |
| 2026-07-31 | 08-04 | Martha Geoffrey | Chairman and CEO | F 繳稅扣股 | 15.8K | 85.39 | 1.4M | 286K | SEC |
| 2026-07-31 | 08-04 | Marinaro Michael | EVP, Pres MedSurg and Americas | F 繳稅扣股 | 3.4K | 85.39 | 287K | 60.3K | SEC |
| 2026-07-31 | 08-04 | Walter Matthew R. | SVP, Chief HR Officer | F 繳稅扣股 | 1.7K | 85.39 | 143K | 34.2K | SEC |
| 2026-07-28 | 07-29 | Quinn Michelle | EVP, GC and Secretary | F 繳稅扣股 | 2.1K | 86.88 | 180K | 20.4K | SEC |
| 2026-07-08 | 07-09 | Walter Matthew R. | SVP, Chief HR Officer | S 公開市場賣出(10b5-1) | 3.1K | 83.15 | 258K | 35.7K | SEC |
| 2026-06-08 | 06-09 | KIIL HARRY SKIP | EVP & President Cardiovascular | S 公開市場賣出 | 228 | 80.45 | 18K | 37.2K | SEC |
| 2026-06-08 | 06-09 | KIIL HARRY SKIP | EVP & President Cardiovascular | S 公開市場賣出 | 4.0K | 80.44 | 319K | 37.5K | SEC |
| 2026-06-05 | 06-08 | Blomquist Denise L. | Chief Accounting Officer | F 繳稅扣股 | 237 | 83.32 | 20K | 14.7K | SEC |
| 2026-06-04 | 06-08 | Martha Geoffrey | Chairman and CEO | F 繳稅扣股 | 41.9K | 83.32 | 3.5M | 301K | SEC |
| 2026-06-04 | 06-08 | Marinaro Michael | EVP, Pres MedSurg and Americas | F 繳稅扣股 | 7.5K | 83.32 | 622K | 63.1K | SEC |
| 2026-06-04 | 06-08 | Walter Matthew R. | SVP, Chief HR Officer | F 繳稅扣股 | 2.8K | 83.32 | 237K | 38.7K | SEC |
| 2026-06-04 | 06-08 | KIIL HARRY SKIP | EVP & President Cardiovascular | F 繳稅扣股 | 6.8K | 83.32 | 568K | 41.4K | SEC |
| 2026-05-26 | 05-28 | Marinaro Michael | EVP, Pres MedSurg and Americas | M 選擇權執行 | 19.0K | – | – | 70.6K | SEC |
| 2026-05-26 | 05-28 | Walter Matthew R. | SVP, Chief HR Officer | M 選擇權執行 | 9.1K | – | – | 41.5K | SEC |
| 2026-05-26 | 05-28 | KIIL HARRY SKIP | EVP & President Cardiovascular | M 選擇權執行 | 15.2K | – | – | 48.2K | SEC |
| 2026-05-26 | 05-28 | Martha Geoffrey | Chairman and CEO | M 選擇權執行 | 95.0K | – | – | 343K | SEC |
| 2026-05-26 | 05-28 | Blomquist Denise L. | Chief Accounting Officer | M 選擇權執行 | 1.7K | – | – | 15.0K | SEC |
| 2026-05-26 | 05-28 | Wall Brett A. | EVP & Pres Neuroscience | M 選擇權執行 | 26.9K | – | – | 82.2K | SEC |
| 2026-05-01 | 05-04 | Walter Matthew R. | SVP, Chief HR Officer | F 繳稅扣股 | 35 | 80.00 | 3K | 32.4K | SEC |
| 2026-04-28 | 04-29 | Blomquist Denise L. | Chief Accounting Officer | F 繳稅扣股 | 318 | 81.90 | 26K | 13.3K | SEC |
| 2026-04-28 | 04-29 | Lewis Gregory P | Director | F 繳稅扣股 | 207 | 81.90 | 17K | 5.8K | SEC |
| 2026-04-28 | 04-29 | NABEL ELIZABETH G | Director | F 繳稅扣股 | 207 | 81.90 | 17K | 19.6K | SEC |
| 2026-04-28 | 04-29 | Lofton Kevin E | Director | F 繳稅扣股 | 207 | 81.90 | 17K | 10.1K | SEC |
| 2026-04-28 | 04-29 | Fonseca Lidia | Director | F 繳稅扣股 | 207 | 81.90 | 17K | 7.6K | SEC |
| 2026-04-28 | 04-29 | Powell Kendall J | Director | F 繳稅扣股 | 207 | 81.90 | 17K | 51.4K | SEC |
| 2026-04-28 | 04-29 | DONNELLY SCOTT C | Director | F 繳稅扣股 | 207 | 81.90 | 17K | 23.7K | SEC |
| 2026-04-28 | 04-29 | ARNOLD CRAIG | Director | F 繳稅扣股 | 207 | 81.90 | 17K | 42.2K | SEC |
| 2026-04-28 | 04-29 | HOGAN RANDALL J | Director | F 繳稅扣股 | 207 | 81.90 | 17K | 49.0K | SEC |
| 2026-04-27 | 04-29 | ARNOLD CRAIG | Director | A 獲配股票 | 2.1K | – | – | 42.4K | SEC |
| 2026-04-27 | 04-29 | Lee Joon Sup | Director | A 獲配股票 | 1.8K | – | – | 1.8K | SEC |
| 2026-04-27 | 04-29 | Blomquist Denise L. | Chief Accounting Officer | A 獲配股票 | 1.5K | – | – | 13.6K | SEC |
| 2026-04-27 | 04-29 | Lewis Gregory P | Director | A 獲配股票 | 2.1K | – | – | 6.0K | SEC |
| 2026-04-27 | 04-29 | NABEL ELIZABETH G | Director | A 獲配股票 | 2.1K | – | – | 19.8K | SEC |
| 2026-04-27 | 04-29 | Groetelaars John P | Director | A 獲配股票 | 1.4K | – | – | 1.4K | SEC |
| 2026-04-27 | 04-29 | Lofton Kevin E | Director | A 獲配股票 | 2.1K | – | – | 10.3K | SEC |
| 2026-04-27 | 04-29 | Fonseca Lidia | Director | A 獲配股票 | 2.1K | – | – | 7.9K | SEC |
| 2026-04-27 | 04-29 | Powell Kendall J | Director | A 獲配股票 | 2.1K | – | – | 51.6K | SEC |
| 2026-04-27 | 04-29 | DONNELLY SCOTT C | Director | A 獲配股票 | 2.1K | – | – | 23.9K | SEC |
| 2026-04-27 | 04-29 | HOGAN RANDALL J | Director | A 獲配股票 | 2.1K | – | – | 49.2K | SEC |
| 2026-04-27 | 04-29 | Jellison William R | Director | A 獲配股票 | 1.4K | – | – | 6.4K | SEC |
| 2026-03-03 | 03-05 | Pieton Thierry | EVP & Chief Financial Officer | F 繳稅扣股 | 3.0K | 96.71 | 288K | 37.6K | SEC |
| 2026-02-20 | 02-24 | Blomquist Denise L. | Chief Accounting Officer | G 贈與 | 340 | – | – | 12.0K | SEC |
| 2026-02-19 | 02-26 | KIIL HARRY SKIP | EVP & President Cardiovascular | S 公開市場賣出 | 668 | 97.83 | 65K | 33.2K | SEC |
| 2026-02-19 | 02-26 | KIIL HARRY SKIP | EVP & President Cardiovascular | S 公開市場賣出 | 19.3K | 97.77 | 1.9M | 33.8K | SEC |
| 2026-02-19 | 02-26 | KIIL HARRY SKIP | EVP & President Cardiovascular | S 公開市場賣出 | 30.6K | 97.66 | 3.0M | 53.1K | SEC |
| 2026-02-19 | 02-26 | KIIL HARRY SKIP | EVP & President Cardiovascular | S 公開市場賣出 | 1.6K | 97.86 | 161K | 83.6K | SEC |
| 2026-02-19 | 02-26 | KIIL HARRY SKIP | EVP & President Cardiovascular | M 選擇權執行 | 385 | 80.00 | 31K | 85.3K | SEC |
| 2026-02-19 | 02-26 | KIIL HARRY SKIP | EVP & President Cardiovascular | S 公開市場賣出 | 385 | 97.82 | 38K | 32.8K | SEC |
| 2026-02-19 | 02-26 | KIIL HARRY SKIP | EVP & President Cardiovascular | M 選擇權執行 | 19.9K | 87.76 | 1.7M | 84.9K | SEC |
| 2026-02-19 | 02-26 | KIIL HARRY SKIP | EVP & President Cardiovascular | M 選擇權執行 | 30.6K | 93.08 | 2.8M | 65.0K | SEC |
| 2026-01-29 | 02-02 | Blomquist Denise L. | Chief Accounting Officer | F 繳稅扣股 | 148 | 101.00 | 15K | 12.3K | SEC |
| 2025-12-15 | 12-17 | Marinaro Michael | EVP, Pres MedSurg and Americas | F 繳稅扣股 | 1.4K | 99.87 | 137K | 50.8K | SEC |
| 2025-12-15 | 12-17 | Martha Geoffrey | Chairman and CEO | F 繳稅扣股 | 1.6K | 99.87 | 156K | 246K | SEC |
| 2025-12-15 | 12-17 | Wall Brett A. | EVP & Pres Neuroscience | F 繳稅扣股 | 439 | 99.87 | 44K | 54.7K | SEC |
| 2025-12-05 | 12-09 | KIIL HARRY SKIP | EVP & President Cardiovascular | F 繳稅扣股 | 1.7K | 101.36 | 173K | 34.2K | SEC |
| 2025-11-20 | 11-24 | Blomquist Denise L. | Chief Accounting Officer | G 贈與 | 170 | – | – | 12.4K | SEC |
| 2025-11-19 | 11-21 | Smith Gregory L | EVP Global Ops & Supply Chain | S 公開市場賣出 | 825 | 102.04 | 84K | 47.1K | SEC |
| 2025-11-19 | 11-21 | Smith Gregory L | EVP Global Ops & Supply Chain | S 公開市場賣出 | 500 | 102.08 | 51K | 46.0K | SEC |
| 2025-11-19 | 11-21 | Smith Gregory L | EVP Global Ops & Supply Chain | S 公開市場賣出 | 2.0K | 102.03 | 204K | 47.9K | SEC |
| 2025-11-19 | 11-21 | Smith Gregory L | EVP Global Ops & Supply Chain | S 公開市場賣出 | 227 | 102.05 | 23K | 46.8K | SEC |
| 2025-11-19 | 11-21 | Smith Gregory L | EVP Global Ops & Supply Chain | S 公開市場賣出 | 1.9K | 101.99 | 198K | 49.9K | SEC |
| 2025-11-19 | 11-21 | Smith Gregory L | EVP Global Ops & Supply Chain | S 公開市場賣出 | 24.2K | 101.93 | 2.5M | 51.8K | SEC |
| 2025-11-19 | 11-21 | Smith Gregory L | EVP Global Ops & Supply Chain | S 公開市場賣出 | 325 | 102.06 | 33K | 46.5K | SEC |
| 2025-09-03 | 09-05 | KIIL HARRY SKIP | EVP & President Cardiovascular | S 公開市場賣出 | 200 | 91.59 | 18K | 35.6K | SEC |
| 2025-09-03 | 09-05 | KIIL HARRY SKIP | EVP & President Cardiovascular | S 公開市場賣出 | 8.4K | 91.58 | 770K | 35.8K | SEC |
| 2025-08-25 | 08-25 | Jellison William R | Director | P 公開市場買進 | 2.5K | 92.37 | 231K | 5.0K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 114M | 8.9B | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 83.8M | 6.6B | 新進 | 新進 |
| STATE STREET CORP | 63.4M | 5.0B | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 34.1M | 2.7B | 新進 | 新進 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 19.9M | 2.6B | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 30.2M | 2.4B | 新進 | 新進 |
| JPMORGAN CHASE & CO | 27.8M | 2.2B | 新進 | 新進 |
| First Eagle Investment Management, LLC | 27.6M | 2.2B | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 21.3M | 1.7B | 新進 | 新進 |
| MORGAN STANLEY | 19.4M | 1.5B | 新進 | 新進 |
| DEUTSCHE BANK AG\ | 18.4M | 1.4B | 新進 | 新進 |
| Invesco Ltd. | 17.9M | 1.4B | 新進 | 新進 |
| FRANKLIN RESOURCES INC | 17.6M | 1.4B | 新進 | 新進 |
| 挪威主權基金 NORGES BANK | 16.6M | 1.3B | 新進 | 新進 |
| ROYAL BANK OF CANADA | 16.0M | 1.3B | 新進 | 新進 |
| Bank of New York Mellon Corp | 14.7M | 1.1B | 新進 | 新進 |
| Capital Research Global Investors | 13.3M | 1.0B | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 12.9M | 1.0B | 新進 | 新進 |
| NORTHERN TRUST CORP | 11.6M | 910M | 新進 | 新進 |
| AMERIPRISE FINANCIAL INC | 11.6M | 905M | 新進 | 新進 |
| WCM INVESTMENT MANAGEMENT, LLC | 10.8M | 876M | 新進 | 新進 |
| Legal & General Group Plc | 9.8M | 769M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 9.0M | 705M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 8.9M | 697M | 新進 | 新進 |
| Capital World Investors | 8.4M | 655M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 2,128 -113 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 2128 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 1.11B · 86.5% |
| 合計季末市值 | 84.6B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 12.1M |
|---|---|
| 與上期比 | -15.4% |
| 佔流通股數 | 0.95% |
| 日均成交量 | 7.3M |
| 回補天數 | 1.7 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 12.1M | -15.4% | 0.95% | 7.3M | 1.7 |
| 2026-08-14 | 14.4M | -20.8% | 1.12% | 6.4M | 2.3 |
| 2026-07-31 | 18.1M | -4.8% | 1.42% | 7.6M | 2.4 |
| 2026-07-15 | 19.0M | -0.3% | 1.49% | 7.8M | 2.5 |
| 2026-06-30 | 19.1M | +3.6% | 1.49% | 11.0M | 1.7 |
| 2026-06-15 | 18.4M | +10.0% | 1.44% | 12.2M | 1.5 |
| 2026-05-29 | 16.8M | +14.4% | 1.31% | 11.3M | 1.5 |
| 2026-05-15 | 14.6M | +0.3% | 1.14% | 9.9M | 1.5 |
| 2026-04-30 | 14.6M | -5.5% | 1.14% | 9.7M | 1.5 |
| 2026-04-15 | 15.5M | -9.0% | 1.21% | 7.5M | 2.1 |
| 2026-03-31 | 17.0M | +2.4% | 1.33% | 8.2M | 2.1 |
| 2026-03-13 | 16.6M | +7.6% | 1.30% | 8.6M | 1.9 |
| 2026-02-27 | 15.4M | -11.0% | 1.21% | 9.0M | 1.7 |
| 2026-02-13 | 17.3M | -12.1% | 1.35% | 9.5M | 1.8 |
| 2026-01-30 | 19.7M | +17.6% | 1.54% | 9.0M | 2.2 |
| 2026-01-15 | 16.8M | +16.5% | 1.31% | 6.9M | 2.4 |
| 2025-12-31 | 14.4M | -4.8% | 1.13% | 5.5M | 2.6 |
| 2025-12-15 | 15.1M | -20.3% | 1.18% | 6.1M | 2.5 |
| 2025-11-28 | 19.0M | +40.2% | 1.48% | 10.5M | 1.8 |
| 2025-11-14 | 13.5M | -6.2% | 1.06% | 6.3M | 2.2 |
| 2025-10-31 | 14.4M | -3.5% | 1.13% | 5.7M | 2.5 |
| 2025-10-15 | 14.9M | +40.2% | 1.17% | 6.9M | 2.2 |
| 2025-09-30 | 10.7M | -16.6% | 0.83% | 8.4M | 1.3 |
| 2025-09-15 | 12.8M | -3.3% | 1.00% | 6.2M | 2.1 |
| 2025-08-29 | 13.2M | -6.1% | 1.03% | 8.2M | 1.6 |
| 2025-08-15 | 14.1M | +21.5% | 1.10% | 6.6M | 2.1 |